Pediatric traumatic brain injury (TBI) is a major public health issue, and a risk factor for the development of post-traumatic epilepsy that may profoundly impact the quality of life for survivors. As the majority of neurotrauma research is focused on injury to the adult brain, our understanding of the developing brain's response to TBI remains incomplete. Neuroinflammation is an influential pathophysiological mechanism in TBI, and is thought to increase neuronal hyperexcitability, rendering the brain more susceptible to the onset of seizures and/or epileptogenesis. We here hypothesized that peripheral blood-derived macrophages, recruited into the injured brain via C-C motif ligand 2 (CCL2) chemokine/C-C chemokine receptor type 2 (CCR2) signaling, contributes to neuroinflammation and thus seizure susceptibility after experimental pediatric TBI. Using Ccr2 gene-deficient mice in the controlled cortical impact (CCI) model of TBI, in 3-week-old male mice we found that TBI led to an increase in susceptibility to pentylenetetrazol (PTZ)-evoked seizures, associated with considerable cortical tissue loss, a robust cellular neuroinflammatory response, and oxidative stress. Intriguingly, although Ccr2-deficiency increased CCL2 levels in serum, it did not exacerbate seizure susceptibility or the neuroinflammatory cellular response after pediatric TBI. Similarly, acute post-injury treatment with a CCR2 antagonist did not influence seizure susceptibility or the extent of tissue damage in wild-type (WT) mice. Together, our findings suggest that CCR2 is not a crucial driver of epileptogenesis or neuroinflammation after TBI in the developing brain. We propose that age may be an important factor differentiating our findings from previous studies in which targeting CCL2/CCR2 has been reported to be anti-inflammatory, neuroprotective or anti-seizure.
Get full access to this article
View all access options for this article.
References
1.
National Center for Health Statistics. Mortality Data on CDC WONDER. Centers for Disease Control and Prevention: Atlanta, GA; 2019.
2.
FaulM, XuL, WaldMM, et al.Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002–2006. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control: Atlanta, GA; 2010.
3.
ThurmanDJ.The epidemiology of traumatic brain injury in children and youths: a review of research since 1990. J Child Neurol, 2016; 31(1):20–27; doi: 10.1177/0883073814544363
4.
TaylorCA, BellJM, BreidingMJ, et al.Traumatic brain injury-related emergency department visits, hospitalizations, and deaths—United States, 2007 and 2013. MMWR Surveill Summ, 2017; 66(9):1–16; doi: 10.1558/5/mmwr.ss6609a1
5.
YeatesKO, SwiftE, TaylorHG, et al.Short- and long-term social outcomes following pediatric traumatic brain injury. J Int Neuropsychol Soc, 2004; 10(3):412–426; doi: 10.1017/S1355617704103093
6.
AndersonVA, CatroppaC, DudgeonP, et al.Understanding predictors of functional recovery and outcome 30 months following early childhood head injury. Neuropsychology, 2006; 20(1):42–57; doi: 10.1037/0894-4105.20.1.42
7.
WalshS, DonnanJ, FortinY, et al.A systematic review of the risks factors associated with the onset and natural progression of epilepsy. Neurotoxicology, 2017; 61:64–77; doi: 10.1016/j.neuro.2016.03.011
8.
LowensteinDH.Epilepsy after head injury: an overview. Epilepsia, 2009; 50(Suppl 2):4–9; doi: 10.1111/j.1528-1167.2008.02004.x
CsukaE, Morganti-KossmannMC, LenzlingerPM, et al.IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol, 1999; 101(2):211–221; doi: 10.1016/s0165-5728(99)00148-4
11.
SempleBD, ByeN, RancanM, et al.Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J Cereb Blood Flow Metab, 2010; 30(4):769–782; doi: 10.1038/jcbfm.2009.262
12.
Morganti-KossmanMC, LenzlingerPM, HansV, et al.Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol Psychiatry, 1997; 2(2):133–136; doi: 10.1038/sj.mp.4000227
13.
DeKoskyST, BlennowK, IkonomovicMD, et al.Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers. Nat Rev Neurol, 2013; 9(4):192–200; doi: 10.1038/nrneurol.2013.36
FarinaC, AloisiF, MeinlE. Astrocytes are active players in cerebral innate immunity. Trends Immunol, 2007; 28(3):138–145; doi: 10.1016/j.it.2007.01.005
16.
ManS, UboguEE, RansohoffRM. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol, 2007; 17(2):243–250; doi: 10.1111/j.1750-3639.2007.00067.x
17.
EngelhardtB.Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J Neurol Sci, 2008; 274(1–2):23–26; doi: 10.1016/j.jns.2008.05.019
18.
YamasakiR, LiuL, LinJ, et al.Role of CCR2 in immunobiology and neurobiology. Clin Exp Neuroimmunol, 2012; 3(1):16–29; doi: 10.1111/j.1759-1961.2011.00024.x
19.
MakindeHM, CudaCM, JustTB, et al.Nonclassical monocytes mediate secondary injury, neurocognitive outcome, and neutrophil infiltration after traumatic brain injury. J Immunol, 2017; 199(10):3583–3591; doi: 10.4049/jimmunol.1700896
20.
SempleBD, KossmannT, Morganti-KossmannMC. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab, 2010; 30(3):459–473; doi: 10.1038/jcbfm.2009.240
21.
PopovichPG, GuanZ, WeiP, et al.Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury. Exp Neurol, 1999; 158(2):351–365; doi: 10.1006/exnr.1999.7118
22.
Rodriguez-PaezAC, BrunschwigJP, BramlettHM. Light and electron microscopic assessment of progressive atrophy following moderate traumatic brain injury in the rat. Acta Neuropathol, 2005; 109(6):603–616; doi: 10.1007/s00401-005-1010-z
23.
MarosoM, BalossoS, RavizzaT, et al.Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics, 2011; 8(2):304–315; doi: 10.1007/s13311-011-0039-z
24.
YuZQ, ZhaJH. Genetic ablation of toll-like receptor 2 reduces secondary brain injury caused by cortical contusion in mice. Ann Clin Lab Sci, 2012; 42(1):26–33.
25.
SanzP, Garcia-GimenoMA. Reactive glia inflammatory signaling pathways and epilepsy. Int J Mol Sci, 2020; 21(11):4096; doi: 10.3390/ijms21114096
26.
WangC, YangL, ZhangJ, et al.Higher expression of monocyte chemoattractant protein 1 and its receptor in brain tissue of intractable epilepsy patients. J Clin Neurosci, 2016; 28:134–140; doi: 10.1016/j.jocn.2015.07.033
27.
de VriesEE, van den MunckhofB, BraunKP, et al.Inflammatory mediators in human epilepsy: a systematic review and meta-analysis. Neurosci Biobehav Rev, 2016; 63:177–190; doi: 10.1016/j.neubiorev.2016.02.007
28.
WuY, WangX, MoX, et al.Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsy. Clin Neuropathol, 2008; 27(03):55–63; doi: 10.5414/npp27055
29.
ZattoniM, MuraML, DeprezF, et al.Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci, 2011; 31(11):4037–5400; doi: 10.1523/JNEUROSCI.6210-10.2011
30.
ManleyNC, BertrandAA, KinneyKS, et al.Characterization of monocyte chemoattractant protein-1 expression following a kainate model of status epilepticus. Brain Res, 2007; 1182:138–143; doi: 10.1016/j.brainres.2007.08.092
31.
VarvelNH, NeherJJ, BoschA, et al.Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus. Proc Natl Acad Sci U S A, 2016; 113(38):E5665–E5674; doi: 10.1073/pnas.1604263113
32.
van GassenKL, NetzebandJG, de GraanPN, et al.The chemokine CCL2 modulates Ca2+ dynamics and electrophysiological properties of cultured cerebellar Purkinje neurons. Eur J Neurosci, 2005; 21(11):2949–2957; doi: 10.1111/j.1460-9568.2005.04113.x
33.
GosselinRD, VarelaC, BanisadrG, et al.Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem, 2005; 95(4):1023–1034; doi: 10.1111/j.1471-4159.2005.03431.x
34.
ZhouY, TangH, LiuJ, et al.Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem, 2011; 116(3):406–414; doi: 10.1111/j.1471-4159.2010.07121.x
35.
SempleBD, O'BrienTJ, GimlinK, et al.Interleukin-1 receptor in seizure susceptibility after traumatic injury to the pediatric brain. J Neurosci, 2017; 37(33):7864–7877; doi: 10.1523/JNEUROSCI.0982-17.2017
36.
VezzaniA, MarosoM, BalossoS, et al.IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun, 2011; 25(7):1281–1289; doi: 10.1016/j.bbi.2011.03.018
37.
TianDS, PengJ, MuruganM, et al.Chemokine CCL2-CCR2 signaling induces neuronal cell death via STAT3 activation and IL-1beta production after status epilepticus. J Neurosci. 2017; 37(33):7878–7892; doi: 10.1523/jneurosci.0315-17.2017
38.
CerriC, GenovesiS, AllegraM, et al.The chemokine CCL2 mediates the seizure-enhancing effects of systemic inflammation. J Neurosci, 2016; 36(13):3777–3788; doi: 10.1523/jneurosci.0451-15.2016
39.
BoringL, GoslingJ, ChensueSW, et al.Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest, 1997; 100(10):2552–2561; doi: 10.1172/JCI119798
40.
TongW, IgarashiT, FerrieroDM, et al.Traumatic brain injury in the immature mouse brain: characterization of regional vulnerability. Exp Neurol, 2002; 176(1):105–116; doi: 10.1006/exnr.2002.7941
LuXM, BrowningJ, LiaoZ, et al.Post-traumatic epilepsy and seizure susceptibility in rat models of penetrating and closed-head brain injury. J Neurotrauma, 2020; 37(2):236–247; doi: 10.1089/neu.2019.6573
44.
RacineRJ.Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol, 1972; 32(3):281–294; doi: 10.1016/0013-4694(72)90177-0
45.
SharmaR, ZamaniA, DillLK, et al.A systemic immune challenge to model hospital-acquired infections independently regulates immune responses after pediatric traumatic brain injury. J Neuroinflammation, 2021; 18(1):72; doi: 10.1186/s12974-021-02114-1
46.
MitchellLA, HansenRJ, BeaupreAJ, et al.Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity. Int Immunopharmacol, 2013; 15(2):357–363; doi: 10.1016/j.intimp.2012.11.016
47.
ChenHR, ChenCW, KuoYM, et al.Monocytes promote acute neuroinflammation and become pathological microglia in neonatal hypoxic-ischemic brain injury. Theranostics, 2022; 12(2):512–529; doi: 10.7150/thno.64033
48.
KumarA, BarrettJP, Alvarez-CrodaDM, et al.NOX2 drives M1-like microglial/macrophage activation and neurodegeneration following experimental traumatic brain injury. Brain Behav Immun, 2016; 58:291–309; doi: 10.1016/j.bbi.2016.07.158
49.
HsiehCL, NiemiEC, WangSH, et al.CCR2 deficiency impairs macrophage infiltration and improves cognitive function after traumatic brain injury. J Neurotrauma, 2014; 31(20):1677–1688; doi: 10.1089/neu.2013.3252
50.
GyonevaS, KimD, KatsumotoA, et al.Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury. J Neuroinflammation, 2015; 12:228; doi: 10.1186/s12974-015-0443-0
51.
SchillingM, StreckerJK, RingelsteinEB, et al.The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice. Brain Res, 2009; 1289:79–84; doi: 10.1016/j.brainres.2009.06.054
52.
DimitrijevicOB, StamatovicSM, KeepRF, et al.Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke, 2007; 38(4):1345–1353; doi: 10.1161/01.STR.0000259709.16654.8f
53.
SchillingM, StreckerJK, SchabitzWR, et al.Effects of monocyte chemoattractant protein 1 on blood-borne cell recruitment after transient focal cerebral ischemia in mice. Neuroscience, 2009; 161(3):806–812; doi: 10.1016/j.neuroscience.2009.04.025
54.
NeriM, FratiA, TurillazziE, et al.Immunohistochemical evaluation of aquaporin-4 and its correlation with CD68, IBA-1, HIF-1alpha, GFAP, and CD15 expressions in fatal traumatic brain injury. Int J Mol Sci, 2018; 19(11); doi: 10.3390/ijms19113544
55.
UtagawaA, BramlettHM, DanielsL, et al.Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats. Brain Res, 2008; 1207:155–163; doi: 10.1016/j.brainres.2008.02.057
56.
MaoM, XuY, ZhangXY, et al.MicroRNA-195 prevents hippocampal microglial/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1/CX3CR1 signaling. J Neuroinflammation, 2020; 17(1):244; doi: 10.1186/s12974-020-01919-w
57.
GlushakovaOY, GlushakovAO, BorlonganCV, et al.Role of caspase-3-mediated apoptosis in chronic caspase-3-cleaved tau accumulation and blood-brain barrier damage in the corpus callosum after traumatic brain injury in rats. J Neurotrauma, 2018; 35(1):157–173; doi: 10.1089/neu.2017.4999
58.
AbeN, ChoudhuryME, WatanabeM, et al.Comparison of the detrimental features of microglia and infiltrated macrophages in traumatic brain injury: a study using a hypnotic bromovalerylurea. Glia, 2018; 66(10):2158–2173; doi: 10.1002/glia.23469
59.
KoenigerT, KuertenS.Splitting the "unsplittable": dissecting resident and infiltrating macrophages in experimental autoimmune encephalomyelitis. Int J Mol Sci, 2017; 18(10); doi: 10.3390/ijms18102072
60.
CardonaAE, SasseME, LiuL, et al.Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood, 2008; 112(2):256–263; doi: 10.1182/blood-2007-10-118497
61.
ChuHX, ArumugamTV, GelderblomM, et al.Role of CCR2 in inflammatory conditions of the central nervous system. J Cereb Blood Flow Metab, 2014; 34(9):1425–1429; doi: 10.1038/jcbfm.2014.120
62.
DyerDP, Medina-RuizL, BartoliniR, et al.Chemokine receptor redundancy and specificity are context dependent. Immunity, 2019; 50(2):378–389.e5; doi: 10.1016/j.immuni.2019.01.009
63.
SquiresRF, SaederupE, CrawleyJN, et al.Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sciences, 1984; 35(14):1439–1444; doi: 10.1016/0024-3205(84)90159-0
64.
BaoYH, BramlettHM, AtkinsCM, et al.Post-traumatic seizures exacerbate histopathological damage after fluid-percussion brain injury. J Neurotrauma, 2011; 28(1):35–42; doi: 10.1089/neu.2010.1383
65.
BolkvadzeT, PitkanenA. Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse. J Neurotrauma, 2012; 29(5):789–812; doi: 10.1089/neu.2011.1954
66.
WebsterKM, SunM, CrackP, et al.Inflammation in epileptogenesis after traumatic brain injury. J Neuroinflammation, 2017; 14(1):10; doi: 10.1186/s12974-016-0786-1
67.
BradyRD, Casillas-EspinosaPM, AgostonDV, et al.Modelling traumatic brain injury and posttraumatic epilepsy in rodents. Neurobiol Dis, 2019; 123:8–19; doi: 10.1016/j.nbd.2018.08.007
68.
GhadiriT, GorjiA, VakilzadehG, et al.Neuronal injury and death following focal mild brain injury: the role of network excitability and seizure. Iran J Basic Med Sci, 2020; 23(1):63–70; doi: 10.2203/8/IJBMS.2019.37558.8932
69.
PeiX, SunQ, ZhangY, et al.PC3-secreted microprotein is a novel chemoattractant protein and functions as a high-affinity ligand for CC chemokine receptor 2. J Immunol, 2014; 192(4):1878–1886; doi: 10.4049/jimmunol.1300758
70.
MirzadeganT, DiehlF, EbiB, et al.Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J Biol Chem, 2000; 275(33):25562–25571; doi: 10.1074/jbc.M000692200
71.
Van CoillieE, Van DammeJ, OpdenakkerG. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev, 1999; 10(1):61–86; doi: 10.1016/s1359-6101(99)00005-2
72.
ForestiML, ArisiGM, CampbellJJ, et al.Treatment with CCR2 antagonist is neuroprotective but does not alter epileptogenesis in the pilocarpine rat model of epilepsy. Epilepsy Behav, 2020; 102:106695; doi: 10.1016/j.yebeh.2019.106695
73.
WebsterKM, SunM, CrackPJ, et al.Age-dependent release of high-mobility group box protein-1 and cellular neuroinflammation after traumatic brain injury in mice. J Comp Neurol, 2019; 527(6):1102–1117; doi: 10.1002/cne.24589
74.
ItohT, ImanoM, NishidaS, et al.Increased apoptotic neuronal cell death and cognitive impairment at early phase after traumatic brain injury in aged rats. Brain Struct Funct, 2013; 218(1):209–220; doi: 10.1007/s00429-012-0394-5
75.
OnyszchukG, HeYY, BermanNE, et al.Detrimental effects of aging on outcome from traumatic brain injury: a behavioral, magnetic resonance imaging, and histological study in mice. J Neurotrauma, 2008; 25(2):153–171; doi: 10.1089/neu.2007.0430
76.
MorgantiJM, RiparipLK, ChouA, et al.Age exacerbates the CCR2/5-mediated neuroinflammatory response to traumatic brain injury. J Neuroinflammation, 2016; 13(1):80; doi: 10.1186/s12974-016-0547-1
77.
ChouA, KrukowskiK, MorgantiJM, et al.Persistent infiltration and impaired response of peripherally-derived monocytes after traumatic brain injury in the aged brain. Int J Mol Sci, 2018; 19(6); doi: 10.3390/ijms19061616
78.
AnthonyD, DempsterR, FearnS, et al.CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood–brain barrier breakdown. Curr Biol, 1998; 8(16):923–927; doi: 10.1016/s0960-9822(07)00373-9
79.
AnthonyDC, BoltonSJ, et al.Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain, 1997; 120 (Pt 3):435–444; doi: 10.1093/brain/120.3.435
80.
SchoderboeckL, AdzemovicM, NicolussiEM, et al.The "window of susceptibility" for inflammation in the immature central nervous system is characterized by a leaky blood-brain barrier and the local expression of inflammatory chemokines. Neurobiol Dis, 2009; 35(3):368–375; doi: 10.1016/j.nbd.2009.05.026
81.
ClausCP, Tsuru-AoyagiK, AdwanikarH, et al.Age is a determinant of leukocyte infiltration and loss of cortical volume after traumatic brain injury. Dev Neurosci, 2010; 32(5-6):454–465; doi: 10.1159/000316805
82.
TackeF, AlvarezD, KaplanTJ, et al.Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest, 2007; 117(1):185–194; doi: 10.1172/JCI28549
83.
TrebstC, Lykke SørensenT, KivisäkkP, et al.CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol, 2001; 159(5):1701–1710; doi: 10.1016/s0002-9440(10)63017-9
84.
DrevetsDA, DillonMJ, SchawangJE, et al.IFN-gamma triggers CCR2-independent monocyte entry into the brain during systemic infection by virulent Listeria monocytogenes. Brain Behav Immun, 2010; 24(6):919–929; doi: 10.1016/j.bbi.2010.02.011
85.
ChuHX, KimHA, LeeS, et al.Evidence of CCR2-independent transmigration of Ly6C(hi) monocytes into the brain after permanent cerebral ischemia in mice. Brain Res, 2016; 1637:118–127; doi: 10.1016/j.brainres.2016.02.030
86.
ChuHX, BroughtonBR, KimHA, et al.Evidence that Ly6C(hi) monocytes are protective in acute ischemic stroke by promoting M2 macrophage polarization. Stroke, 2015; 46(7):1929–1937; doi: 10.1161/STROKEAHA.115.009426
87.
FengL, MuruganM, BoscoDB, et al.Microglial proliferation and monocyte infiltration contribute to microgliosis following status epilepticus. Glia, 2019; 67(8):1434–1448; doi: 10.1002/glia.23616
88.
BermanJW, GuidaMP, WarrenJ, et al.Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol, 1996; 156(8):3017–3023.
89.
GlabinskiAR, BalasingamV, TaniM, et al.Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol, 1996; 156(11):4363.
90.
SomebangK, RudolphJ, ImhofI, et al.CCR2 deficiency alters activation of microglia subsets in traumatic brain injury. Cell Rep, 2021; 36(12):109727; doi: 10.1016/j.celrep.2021.109727
91.
BeschornerR, AdjodahD, SchwabJM, et al.Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol, 2000; 100(4):377–384; doi: 10.1007/s004010000202
CousarJL, LaiY, MarcoCD, et al.Heme oxygenase 1 in cerebrospinal fluid from infants and children after severe traumatic brain injury. Dev Neurosci, 2006; 28(4-5):342–347; doi: 10.1159/000094160
94.
Chen-RoetlingJ, SongW, SchipperHM, et al.Astrocyte overexpression of heme oxygenase-1 improves outcome after intracerebral hemorrhage. Stroke, 2015; 46(4):1093–1098; doi: 10.1161/STROKEAHA.115.008686
95.
LiangC, CangJ, WangH, et al.Propofol attenuates cerebral ischemia/reperfusion injury partially using heme oxygenase-1. J Neurosurg Anesthesiol, 2013; 25(3):311–316; doi: 10.1097/ANA.0b013e31828c6af5
96.
LiC, YuTY, GongLR, et al.Involvement of Nrf-2/HO-1 pathway in sevoflurane-induced cognitive improvement in rats with traumatic brain injury. Behav Brain Res, 2021; 405:113200; doi: 10.1016/j.bbr.2021.113200
97.
FrielerRA, NadimpalliS, BolandLK, et al.Depletion of macrophages in CD11b diphtheria toxin receptor mice induces brain inflammation and enhances inflammatory signaling during traumatic brain injury. Brain Res, 2015; 1624:103–12; doi: 10.1016/j.brainres.2015.07.011
98.
MorgantiJM, JopsonTD, LiuS, et al.CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury. J Neurosci, 2015; 35(2):748–760; doi: 10.1523/JNEUROSCI.2405-14.2015
99.
AertkerBM, KumarA, PrabhakaraKS, et al.Pre-injury monocyte/macrophage depletion results in increased blood-brain barrier permeability after traumatic brain injury. J Neurosci Res, 2019; 97(6):698–707; doi: 10.1002/jnr.24395
100.
WernerY, MassE, Ashok KumarP, et al.Cxcr4 distinguishes HSC-derived monocytes from microglia and reveals monocyte immune responses to experimental stroke. Nat Neurosci, 2020; 23(3):351–362; doi: 10.1038/s41593-020-0585-y
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
